EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Genome sequencing identifies monogenic causes in adults with metabolic diseases

Volkan Okur iD, Amanda Marcus iD, John N Falcone, Maurice A Hurd, Sarah L Stewart, Katerine Claudio, Jyothi Manohar, Fana Dealla, Sonal Kumar, Michele Yeung, Gregory Dakin, Omar Bellorin-Marin und 26 weitere

Journal of the Endocrine Society · 03.06.2026 · 10 (7)

DOI: 10.1210/jendso/bvag091 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Endocrine Society, online erschienen am 10.04.2026. Verfasst von Volkan Okur und 37 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Diagnostics, New York Genome Center, New York, NY 10013, USA. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Englander Precision Medicine Institute at Weill Cornell Medicine, Manoogian Simone Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

A subset of metabolic diseases is caused by rare monogenic variants. Next-generation sequencing offers a promising approach for identifying such variants, but its application in clinical diagnostics for metabolic disease is limited and the diagnostic yield is unknown.

Objective

To determine the diagnostic yield of clinical genome sequencing (GS) in adults presenting with common metabolic diseases.

Methods

We performed clinical GS on 560 adults seen in New York clinical practices between August 2020 and December 2023. Participants presented with hyperlipidemia/hypertriglyceridemia (HLD/HTG), pre-diabetes, Type 2 diabetes mellitus (T2DM), and/or metabolic dysfunction-associated fatty liver disease/steatohepatitis (MAFLD/MASH). Variants in a curated set of 90 genes associated with monogenic forms of these conditions were classified as Pathogenic (P), Likely Pathogenic (LP), or Variant of Uncertain Significance (VUS) using ACMG/ClinGen guidelines. P/LP variants in ACMG secondary findings (v3.1) genes were also reported with participant consent.

Results

The cohort had a female-to-male ratio of 1.7, with 18.6% African American and 22.6% Latino participants. The most common enrollment diagnoses were HLD/HTG (25%), T2DM (9%), pre-diabetes (7%), and MAFLD/MASH (4%). Many participants had multiple conditions (42% with two, 12% with three). Approximately one-third had reportable variants, with 6% classified as P/LP. The most common P/LP variants were in APOB and LDLR.

Conclusion

The prevalence of clinically significant (P/LP) variants related to primary metabolic disease in this cohort was 6%. An additional 5.5% of participants had P/LP variants in ACMG secondary findings genes. Future studies should refine participant selection for genome sequencing to optimize its diagnostic and clinical value.

Schlagwörter

Stichwörter der Autor:innen

NGSdiabetesgenome sequencinghyperlipidemiametabolic disease

Autor:innen und Institutionen

  • Molecular Diagnostics, New York Genome Center, New York, NY 10013, USA.
  • Division of Endocrinology, Department of Medicine, Weill Cornell Medicine, New York, NY 10021, USA.
  • Holman Division of Endocrinology, Diabetes & Metabolism, Department of Medicine, NYU Grossman School of Medicine, New York, NY 10016, USA.
  • Weill Cornell Medical College, New York, NY 10065, USA.
  • Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY 10021, USA.
  • Division of Gastroenterology and Hepatology, Department of Medicine, Weill Cornell Medicine, New York, NY 10065, USA.

ORCID-Profile: Volkan Okur, Amanda Marcus, Lisa C Hudgins, Caroline Nava, Shuibing Chen, Megan J Ritter, Laura C Alonso, Olivier Elemento, Marcus D Goncalves

Förderung

  • Englander Precision Medicine Institute at Weill Cornell Medicine
  • Manoogian Simone Foundation

Zitieren

APA

Okur, V., Marcus, A., Falcone, J. N., Hurd, M. A., Stewart, S. L., Claudio, K., Manohar, J., Dealla, F., Kumar, S., Yeung, M., Dakin, G., Bellorin-Marin, O., Afaneh, C., Hudgins, L. C., Wei, E., Gingras, L., King, A., Tung, J., Rehman, A. U., …, & Goncalves, M. D. (2026). Genome sequencing identifies monogenic causes in adults with metabolic diseases. Journal of the Endocrine Society, 10(7). https://doi.org/10.1210/jendso/bvag091

Vancouver

Okur V, Marcus A, Falcone JN, Hurd MA, Stewart SL, Claudio K, et al. Genome sequencing identifies monogenic causes in adults with metabolic diseases. Journal of the Endocrine Society. 2026;10(7). doi:10.1210/jendso/bvag091

BibTeX
@article{Okur2026,
  author = {Okur, Volkan and Marcus, Amanda and Falcone, John N and Hurd, Maurice A and Stewart, Sarah L and Claudio, Katerine and Manohar, Jyothi and Dealla, Fana and Kumar, Sonal and Yeung, Michele and Dakin, Gregory and Bellorin-Marin, Omar and Afaneh, Cheguevara and Hudgins, Lisa C and Wei, Esther and Gingras, Laura and King, Alexandra and Tung, Judy and Rehman, Atteeq U and Thomas-Wilson, Amanda and Guha, Saurav and Abhyankar, Avinash and Wilson, Ashley L and Khan, Shahid Yar and Srinivasa, Sowmya Thirumalai and Phadke, Shruti and Krithivasan, Priya and Nava, Caroline and Chen, Shuibing and Smith, Ryan and MacDonald, Theresa Y and Ritter, Megan J and Alonso, Laura C and Elemento, Olivier and Udler, Miriam S and Peña, Jessica M and Jobanputra, Vaidehi and Goncalves, Marcus D},
  title = {Genome sequencing identifies monogenic causes in adults with metabolic diseases},
  journal = {Journal of the Endocrine Society},
  year = {2026},
  volume = {10},
  number = {7},
  doi = {10.1210/jendso/bvag091}
}
Kostenlos starten →